| 1 |
33222668 | OSI-027 Alleviates Oxaliplatin Chemoresistance in Gastric Cancer Cells by Suppressing P-gp Induction. | 2021 |
1 |
| 2 |
35096817 | Dual Inhibition of mTORC1/2 Reduces Migration of Cholangiocarcinoma Cells by Regulation of Matrixmetalloproteinases. | 2021 |
1 |
| 3 |
30650200 | Targeting mTORC1/2 with OSI-027 inhibits proliferation and migration of keloid keratinocytes. | 2019 Mar |
1 |
| 4 |
22476852 | Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer. | 2012 Aug |
1 |
| 5 |
23226094 | Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models. | 2012 Nov |
1 |
| 6 |
21673091 | Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin. | 2011 Aug |
2 |